HepaRegeniX GmbH kündigt Management-Wechsel an: Dr. Michael Lutz zum neuen CEO/Geschäftsführer benannt
Dr. Lutz is an experienced biotech entrepreneur who has spent the last 15 years at executive management positions with several Life Sciences companies which he successfully established...